Results 161 to 170 of about 382,649 (338)

LncRNA IRAIN overcomes imatinib resistance in chronic myeloid leukemia via NF-κB/CD44 pathway inhibition

iScience
Summary: The development of tyrosine kinase inhibitors (TKIs) has revolutionarily increased the overall survival of patients with chronic myeloid leukemia (CML). However, drug resistance remains a major obstacle.
Xijia Wang, Yutong Hou, Yizhu Lyu, Jiayin Zhou, Xin Zhang, Mohammad Arian Hassani, Dan Huang, Zhijia Zhao, Dong Zhou, Fang Xie, Xuehong Zhang, Jinsong Yan   +11 more
doaj  

PB1969: PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND CORONAVIRUS DISEASE 2019 IN THE OMICRON ERA

HemaSphere, 2023
Feiyang Qi, Mei Bao, Xiaoshuai Zhang, Shasha Zhao, Wenwen LI, Chenglei Wang, Qian Jiang   +6 more
doaj   +1 more source

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

Science Translational Medicine, 2016
Y. Shono, Melissa Docampo, J. Peled, S. M. Perobelli, E. Velardi, J. Tsai, Ann E. Slingerland, O. Smith, L. Young, J. Gupta, Sophia R Lieberman, Hillary V. Jay, Katya Ahr, Kori A. Porosnicu Rodriguez, Ke Xu, Marco Calarfiore, Hendrik Poeck, S. Caballero, S. Devlin, Franck Rapaport, J. Dudakov, A. Hanash, B. Gyurkocza, G. Murphy, C. Gomes, Chen Liu, Eli Moss, S. Falconer, A. Bhatt, Y. Taur, E. Pamer, M. V. D. van den Brink, R. Jenq   +32 more
semanticscholar   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

Epilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Table of contents, abbreviations, and contributors for the Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients

, 2000

openalex   +1 more source

Pathways to Progressive Disability in Multiple Sclerosis: The Role of Glial Cells in Chronic CNS Inflammation

Glia, EarlyView.
Multiple sclerosis involves chronic CNS inflammation and neurodegeneration. This review highlights glial cells as key drivers in progressive MS, focusing on lesion pathology, molecular dysfunction, and human‐relevant model systems. ABSTRACT Multiple sclerosis (MS) is the most common non‐infectious inflammatory CNS disease, characterized by progressive ...
Volker Siffrin
wiley   +1 more source

Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation [PDF]

, 2001
Peter B. Bach, Deborah Schrag, David M. Nierman, David Hořák, Peter White, James W. Young, Jeffrey S. Groeger   +6 more
openalex   +1 more source

Treatment of autoimmune diseases by hematopoietic stem cell transplantation [PDF]

, 2001
Susumu Ikehara
openalex   +1 more source

Current status of umbilical cord blood hematopoietic stem cell transplantation

, 2000
Éliane Gluckman
openalex   +1 more source

P786: ANTI-PD-1 ANTIBODY (SINTILIMAB) PLUS DECITABINE AS FIRST LINE TREATMENT FOR PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME（MDS）: PRELIMINARY RESULTS FROM A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY

HemaSphere, 2022
J. wang, S. li, H. Jiang, Y. Chang, X. Zhao, J. Jia, X. Zhu, L. Gong, X. Liu, W. Yu, X. Huang   +10 more
doaj   +1 more source